Table 4.
Predictors of all-cause mortality in the study hypertensive population.
| Univariate |
Multivariate |
|||
|---|---|---|---|---|
| OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
| Hospital | 3.457 (2.094–5.706) | <0.001 | ||
| Age (years) | 1.077 (1.053–1.101) | <0.001 | 1.078 (1.050–1.106) | <0.001 |
| Diabetes mellitus | 2.587 (1.643–4.072) | <0.001 | 2.456 (1.375–4.389) | 0.002 |
| Chronic kidney disease | 2.700 (1.494–4.879) | 0.001 | ||
| COPD | 2.328 (1.231–4.403) | 0.009 | ||
| Ischemic heart disease | 1.627 (0.894–2.960) | 0.111 | ||
| ACEi | 0.654 (0.407–1.048) | 0.078 | 0.444 (0.224–0.881) | 0.02 |
| ARB | 0.892 (0.578–1.377) | 0.607 | ||
| Lymphocyte < 1000 mm3 | 1.566 (1.006–2.438) | 0.047 | ||
| Lactate dehydrogenase > 500 U/L | 2.023 (1.198–3.419) | 0.008 | ||
| C-reactive protein | 4.666 (2.319–9.388) | <0.001 | 3.441 (1.455–8.135) | 0.005 |
| D-Dimer > 500 | 2.167 (1.202–3.905) | 0.01 | ||
| Creatinine > 1.5 mg/dL | 5.309 (3.257–8.652) | <0.001 | 5.126 (2.796–9.357) | <0.001 |
Abbreviations: ACEi: Angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blocker; COPD: Chronic obstructive pulmonary disease.
Hosmer–Lemeshow, p = 0.530 AUC 0.836 (0.793, 0.878).